Aktis Oncology Inc (AKTS)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 1 |
| Ownership rank: | 866 |
| % of all portfolios: | 0% |
| |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
0 |
$0 |
| Sells |
11 |
$3,231,413 |
Open Market Insider Buys
| Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
| 14 Jan 2026 |
FOLEY TODD |
Director , 10% |
12 Jan 2026 |
232,870 |
18.00 |
4,191,660 |
| 14 Jan 2026 |
MPM BIOVENTURES 2018, L.P. |
10% |
12 Jan 2026 |
1,112,777 |
18.00 |
20,029,986 |
| 12 Jan 2026 |
ECOR1 CAPITAL, LLC |
Director |
12 Jan 2026 |
144,443 |
18.00 |
2,599,974 |
| 12 Jan 2026 |
ECOR1 CAPITAL, LLC |
Director |
12 Jan 2026 |
2,077,779 |
18.00 |
37,400,022 |
| 12 Jan 2026 |
KIM HELEN SUSAN |
Director , 10% |
12 Jan 2026 |
22,545 |
18.00 |
405,810 |
| 12 Jan 2026 |
KIM HELEN SUSAN |
Director , 10% |
12 Jan 2026 |
812,455 |
18.00 |
14,624,190 |
| 31 Jan 2024 |
GEISS ARTHUR |
Director |
29 Jan 2024 |
50,000 |
0.50 |
25,000 |
| 31 Jan 2024 |
AICHELE DAVID |
EVP of Business Development |
29 Jan 2024 |
80,000 |
0.50 |
40,000 |
| 31 Jan 2024 |
BOLLER KENNETH |
CFO |
29 Jan 2024 |
60,000 |
0.50 |
30,000 |
| 31 Jan 2024 |
SHEALY JEFFREY B. |
Chief Executive Officer |
29 Jan 2024 |
1,310,000 |
0.50 |
655,000 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock